 | • レポートコード：QY2108PAL8945 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける毒素の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、毒素の種類別市場規模（50U、100U、その他）、用途別市場規模（医療、化粧品）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の毒素市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における毒素の種類別市場規模（2016年-2027年）：50U、100U、その他 ・世界における毒素の用途別市場規模（2016年-2027年）：医療、化粧品 ・毒素の中国市場分析 - 毒素の中国市場規模（2016年-2027年） - 中国における毒素の主要プレイヤー別市場シェア - 中国における毒素の種類別市場規模：50U、100U、その他 - 中国における毒素の用途別市場規模：医療、化粧品 ・毒素の北米市場（2016年-2027年） ・毒素のヨーロッパ市場（2016年-2027年） ・毒素のアジア太平洋市場（2016年-2027年） ・毒素の中南米市場（2016年-2027年） ・毒素の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Allergan、Ipsen、Medytox、LIBP、Merz Pharmaceuticals、US World Meds、Hugel、Daewoong ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Global Toxin key players include Allergan, LIBP, Hugel, Ipsen, Medytox, etc. Global top five manufacturers hold a share about 90%.
Europe is the largest market, with a share over 10%, followed by APAC, and Middle East ＆ Africa, both have a share over 20%.
In terms of product, 50U is the largest segment, with a share about 55%. And in terms of application, the largest application is Cosmetic, followed by Medical, etc.
Market Analysis and Insights: Global and China Toxin Market
This report focuses on global and China Toxin market.
In 2020, the global Toxin market size was US$ 4364 million and it is expected to reach US$ 8231.4 million by the end of 2027, with a CAGR of 9.8% during 2021-2027. In China the Toxin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Toxin Scope and Market Size
Toxin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Toxin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Toxin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
1 Study Coverage
1.1 Toxin Product Introduction
1.2 Market by Type
1.2.1 Global Toxin Market Size Growth Rate by Type
1.2.2 50U
1.2.3 100U
1.2.4 Others
1.3 Market by Application
1.3.1 Global Toxin Market Size Growth Rate by Application
1.3.2 Medical
1.3.3 Cosmetic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Toxin Market Size, Estimates and Forecasts
2.1.1 Global Toxin Revenue 2016-2027
2.1.2 Global Toxin Sales 2016-2027
2.2 Global Toxin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Toxin Historical Market Size by Region (2016-2021)
2.3.1 Global Toxin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Toxin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Toxin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Toxin Sales Forecast by Region (2022-2027)
2.4.2 Global Toxin Revenue Forecast by Region (2022-2027)
3 Global Toxin Competitor Landscape by Players
3.1 Global Top Toxin Manufacturers by Sales
3.1.1 Global Toxin Sales by Manufacturer (2016-2021)
3.1.2 Global Toxin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Toxin Manufacturers by Revenue
3.2.1 Key Toxin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Toxin Revenue by Manufacturers (2016-2021)
3.2.3 Global Toxin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Toxin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Toxin Revenue in 2020
3.2.6 Global Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Toxin Price by Manufacturers
3.4 Global Toxin Manufacturing Base Distribution, Product Types
3.4.1 Toxin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Toxin Product Type
3.4.3 Date of International Manufacturers Enter into Toxin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Toxin Market Size by Type (2016-2021)
4.1.1 Global Toxin Sales by Type (2016-2021)
4.1.2 Global Toxin Revenue by Type (2016-2021)
4.1.3 Toxin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Toxin Market Size Forecast by Type (2022-2027)
4.2.1 Global Toxin Sales Forecast by Type (2022-2027)
4.2.2 Global Toxin Revenue Forecast by Type (2022-2027)
4.2.3 Toxin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Toxin Market Size by Application (2016-2021)
5.1.1 Global Toxin Sales by Application (2016-2021)
5.1.2 Global Toxin Revenue by Application (2016-2021)
5.1.3 Toxin Price by Application (2016-2021)
5.2 Toxin Market Size Forecast by Application (2022-2027)
5.2.1 Global Toxin Sales Forecast by Application (2022-2027)
5.2.2 Global Toxin Revenue Forecast by Application (2022-2027)
5.2.3 Global Toxin Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Toxin Market Size YoY Growth 2016-2027
6.1.1 China Toxin Sales YoY Growth 2016-2027
6.1.2 China Toxin Revenue YoY Growth 2016-2027
6.1.3 China Toxin Market Share in Global Market 2016-2027
6.2 China Toxin Market Size by Players (International and Local Players)
6.2.1 China Top Toxin Players by Sales (2016-2021)
6.2.2 China Top Toxin Players by Revenue (2016-2021)
6.3 China Toxin Historic Market Review by Type (2016-2021)
6.3.1 China Toxin Sales Market Share by Type (2016-2021)
6.3.2 China Toxin Revenue Market Share by Type (2016-2021)
6.3.3 China Toxin Price by Type (2016-2021)
6.4 China Toxin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Toxin Sales Forecast by Type (2022-2027)
6.4.2 China Toxin Revenue Forecast by Type (2022-2027)
6.4.3 China Toxin Price Forecast by Type (2022-2027)
6.5 China Toxin Historic Market Review by Application (2016-2021)
6.5.1 China Toxin Sales Market Share by Application (2016-2021)
6.5.2 China Toxin Revenue Market Share by Application (2016-2021)
6.5.3 China Toxin Price by Application (2016-2021)
6.6 China Toxin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Toxin Sales Forecast by Application (2022-2027)
6.6.2 China Toxin Revenue Forecast by Application (2022-2027)
6.6.3 China Toxin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Toxin Market Size YoY Growth 2016-2027
7.2 North America Toxin Market Facts & Figures by Country
7.2.1 North America Toxin Sales by Country (2016-2021)
7.2.2 North America Toxin Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Toxin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Toxin Market Facts & Figures by Region
8.2.1 Asia Pacific Toxin Sales by Region (2016-2021)
8.2.2 Asia Pacific Toxin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Toxin Market Size YoY Growth 2016-2027
9.2 Europe Toxin Market Facts & Figures by Country
9.2.1 Europe Toxin Sales by Country (2016-2021)
9.2.2 Europe Toxin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Toxin Market Size YoY Growth 2016-2027
10.2 Latin America Toxin Market Facts & Figures by Country
10.2.1 Latin America Toxin Sales by Country (2016-2021)
10.2.2 Latin America Toxin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
10.2.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Toxin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Toxin Market Facts & Figures by Country
11.2.1 Middle East and Africa Toxin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Toxin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Toxin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Toxin Products Offered
12.1.5 Allergan Recent Development
12.2 Ipsen
12.2.1 Ipsen Corporation Information
12.2.2 Ipsen Description and Business Overview
12.2.3 Ipsen Toxin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Ipsen Toxin Products Offered
12.2.5 Ipsen Recent Development
12.3 Medytox
12.3.1 Medytox Corporation Information
12.3.2 Medytox Description and Business Overview
12.3.3 Medytox Toxin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Medytox Toxin Products Offered
12.3.5 Medytox Recent Development
12.4 LIBP
12.4.1 LIBP Corporation Information
12.4.2 LIBP Description and Business Overview
12.4.3 LIBP Toxin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 LIBP Toxin Products Offered
12.4.5 LIBP Recent Development
12.5 Merz Pharmaceuticals
12.5.1 Merz Pharmaceuticals Corporation Information
12.5.2 Merz Pharmaceuticals Description and Business Overview
12.5.3 Merz Pharmaceuticals Toxin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merz Pharmaceuticals Toxin Products Offered
12.5.5 Merz Pharmaceuticals Recent Development
12.6 US World Meds
12.6.1 US World Meds Corporation Information
12.6.2 US World Meds Description and Business Overview
12.6.3 US World Meds Toxin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 US World Meds Toxin Products Offered
12.6.5 US World Meds Recent Development
12.7 Hugel
12.7.1 Hugel Corporation Information
12.7.2 Hugel Description and Business Overview
12.7.3 Hugel Toxin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hugel Toxin Products Offered
12.7.5 Hugel Recent Development
12.8 Daewoong
12.8.1 Daewoong Corporation Information
12.8.2 Daewoong Description and Business Overview
12.8.3 Daewoong Toxin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Daewoong Toxin Products Offered
12.8.5 Daewoong Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Toxin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Toxin Products Offered
12.11.5 Allergan Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Toxin Industry Trends
13.2 Toxin Market Drivers
13.3 Toxin Market Challenges
13.4 Toxin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Toxin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Toxin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 50U
Table 3. Major Manufacturers of 100U
Table 4. Major Manufacturers of Others
Table 5. Global Toxin Market Size Growth Rate by Application (2021-2027) & (K Vial)
Table 6. Global Toxin Market Size by Region (K Vial) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Toxin Sales by Regions (2016-2021) & (K Vial)
Table 8. Global Toxin Sales Market Share by Regions (2016-2021)
Table 9. Global Toxin Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Toxin Sales Forecast by Region (2022-2027) & (K Vial)
Table 11. Global Toxin Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Toxin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Toxin Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Toxin Sales by Manufacturers (2016-2021) (K Vial)
Table 15. Global Toxin Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Toxin Manufacturers by Revenue (US$ Million) in 2020
Table 17. Toxin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Toxin Revenue Share by Manufacturers (2016-2021)
Table 19. Global Toxin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Toxin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxin as of 2020)
Table 21. Key Manufacturers Toxin Price (2016-2021) (US$/Vial)
Table 22. Toxin Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Toxin Product Type
Table 24. Date of International Manufacturers Enter into Toxin Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Toxin Sales by Type (2016-2021) (K Vial)
Table 27. Global Toxin Sales Share by Type (2016-2021)
Table 28. Global Toxin Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Toxin Revenue Share by Type (2016-2021)
Table 30. Toxin Average Selling Price (ASP) by Type (2016-2021) & (US$/Vial)
Table 31. Global Toxin Sales Forecast by Type (2022-2027) & (K Vial)
Table 32. Global Toxin Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Toxin Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Toxin Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Toxin Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Vial)
Table 36. Global Toxin Sales by Application (2016-2021) (K Vial)
Table 37. Global Toxin Sales Share by Application (2016-2021)
Table 38. Global Toxin Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Toxin Revenue Share by Application (2016-2021)
Table 40. Toxin Average Selling Price (ASP) by Application (2016-2021) & (US$/Vial)
Table 41. Global Toxin Sales Forecast by Application (2022-2027) & (K Vial)
Table 42. Global Toxin Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Toxin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Toxin Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Toxin Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Vial)
Table 46. China Toxin Sales (K Vial) of Key Companies (2016-2021)
Table 47. China Toxin Sales Share by Company (2016-2021)
Table 48. China Toxin Revenue (US$ Million) by Company (2016-2021)
Table 49. China Toxin Revenue Share by Company (2016-2021)
Table 50. China Toxin Sales (K Vial) by Type (2016-2021)
Table 51. China Toxin Sales Share by Type (2016-2021)
Table 52. China Toxin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Toxin Price (US$/Vial) by Type (2016-2021)
Table 54. China Toxin Sales (K Vial) by Type (2022-2027)
Table 55. China Toxin Sales Share by Type (2022-2027)
Table 56. China Toxin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Toxin Revenue Share by Type (2022-2027)
Table 58. China Toxin Price (US$/Vial) by Type (2022-2027)
Table 59. China Toxin Sales (K Vial) by Application (2016-2021)
Table 60. China Toxin Sales Share by Application (2016-2021)
Table 61. China Toxin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Toxin Price (US$/Vial) by Application (2016-2021)
Table 63. China Toxin Sales (K Vial) by Application (2022-2027)
Table 64. China Toxin Sales Share by Application (2022-2027)
Table 65. China Toxin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Toxin Revenue Share by Application (2022-2027)
Table 67. China Toxin Price (US$/Vial) by Application (2022-2027)
Table 68. North America Toxin Sales by Country (2016-2021) & (K Vial)
Table 69. North America Toxin Sales Market Share by Country (2016-2021)
Table 70. North America Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Toxin Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Toxin Sales by Region (2016-2021) & (K Vial)
Table 73. Asia Pacific Toxin Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Toxin Revenue Market Share by Region (2016-2021)
Table 76. Europe Toxin Sales by Country (2016-2021) & (K Vial)
Table 77. Europe Toxin Sales Market Share by Country (2016-2021)
Table 78. Europe Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Toxin Revenue Market Share by Country (2016-2021)
Table 80. Latin America Toxin Sales by Country (2016-2021) & (K Vial)
Table 81. Latin America Toxin Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Toxin Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Toxin Sales by Country (2016-2021) & (K Vial)
Table 85. Middle East and Africa Toxin Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Toxin Revenue Market Share by Country (2016-2021)
Table 88. Allergan Corporation Information
Table 89. Allergan Description and Business Overview
Table 90. Allergan Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 91. Allergan Toxin Product
Table 92. Allergan Recent Development
Table 93. Ipsen Corporation Information
Table 94. Ipsen Description and Business Overview
Table 95. Ipsen Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 96. Ipsen Product
Table 97. Ipsen Recent Development
Table 98. Medytox Corporation Information
Table 99. Medytox Description and Business Overview
Table 100. Medytox Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 101. Medytox Product
Table 102. Medytox Recent Development
Table 103. LIBP Corporation Information
Table 104. LIBP Description and Business Overview
Table 105. LIBP Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 106. LIBP Product
Table 107. LIBP Recent Development
Table 108. Merz Pharmaceuticals Corporation Information
Table 109. Merz Pharmaceuticals Description and Business Overview
Table 110. Merz Pharmaceuticals Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 111. Merz Pharmaceuticals Product
Table 112. Merz Pharmaceuticals Recent Development
Table 113. US World Meds Corporation Information
Table 114. US World Meds Description and Business Overview
Table 115. US World Meds Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 116. US World Meds Product
Table 117. US World Meds Recent Development
Table 118. Hugel Corporation Information
Table 119. Hugel Description and Business Overview
Table 120. Hugel Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 121. Hugel Product
Table 122. Hugel Recent Development
Table 123. Daewoong Corporation Information
Table 124. Daewoong Description and Business Overview
Table 125. Daewoong Toxin Sales (K Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2016-2021)
Table 126. Daewoong Product
Table 127. Daewoong Recent Development
Table 128. Toxin Market Trends
Table 129. Toxin Market Drivers
Table 130. Toxin Market Challenges
Table 131. Toxin Market Restraints
Table 132. Toxin Customers List
Table 133. Toxin Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Toxin Product Picture
Figure 2. Global Toxin Sales Market Share by Type in 2020 & 2027
Figure 3. 50U Product Picture
Figure 4. 100U Product Picture
Figure 5. Others Product Picture
Figure 6. Global Toxin Sales Market Share by Application in 2020 & 2027
Figure 7. Medical
Figure 8. Cosmetic
Figure 9. Toxin Report Years Considered
Figure 10. Global Toxin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Toxin Market Size 2016-2027 (US$ Million)
Figure 12. Global Toxin Sales 2016-2027 (K Vial)
Figure 13. Global Toxin Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Toxin Sales Market Share by Region (2016-2021)
Figure 15. Global Toxin Sales Market Share by Region in 2020
Figure 16. Global Toxin Revenue Market Share by Region (2016-2021)
Figure 17. Global Toxin Revenue Market Share by Region in 2020
Figure 18. Global Toxin Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Toxin Revenue in 2020
Figure 20. Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Toxin Sales Market Share by Type (2016-2021)
Figure 22. Global Toxin Sales Market Share by Type in 2020
Figure 23. Global Toxin Revenue Market Share by Type (2016-2021)
Figure 24. Global Toxin Revenue Market Share by Type in 2020
Figure 25. Global Toxin Sales Market Share by Application (2016-2021)
Figure 26. Global Toxin Sales Market Share by Application in 2020
Figure 27. Global Toxin Revenue Market Share by Application (2016-2021)
Figure 28. Global Toxin Revenue Market Share by Application in 2020
Figure 29. China Toxin Sales Growth Rate 2016-2027 (K Vial)
Figure 30. China Toxin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Toxin Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Toxin Players Market Share by Revenue in Toxin in 2020
Figure 33. China Toxin Revenue Share by Type (2016-2021)
Figure 34. China Toxin Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Toxin Revenue Share by Application (2016-2021)
Figure 36. China Toxin Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Toxin Sales Growth Rate 2016-2021 (K Vial)
Figure 38. North America Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Toxin Sales Market Share by Country in 2020
Figure 40. North America Toxin Revenue Market Share by Country in 2020
Figure 41. United States Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 42. United States Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 44. Canada Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Toxin Sales Growth Rate 2016-2021 (K Vial)
Figure 46. Europe Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Toxin Sales Market Share by Country in 2020
Figure 48. Europe Toxin Revenue Market Share by Country in 2020
Figure 49. Germany Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 50. Germany Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 52. France Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 54. U.K. Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 56. Italy Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 58. Russia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Toxin Sales Growth Rate 2016-2021 (K Vial)
Figure 60. Asia Pacific Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Toxin Sales Market Share by Region in 2020
Figure 62. Asia Pacific Toxin Revenue Market Share by Region in 2020
Figure 63. China Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 64. China Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 66. Japan Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 68. South Korea Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 70. India Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 72. Australia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 74. China Taiwan Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 76. Indonesia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 78. Thailand Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 80. Malaysia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Toxin Sales Growth Rate 2016-2021 (K Vial)
Figure 82. Latin America Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Toxin Sales Market Share by Country in 2020
Figure 84. Latin America Toxin Revenue Market Share by Country in 2020
Figure 85. Mexico Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 86. Mexico Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 88. Brazil Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 90. Argentina Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Colombia Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 92. Colombia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Toxin Sales Growth Rate 2016-2021 (K Vial)
Figure 94. Middle East and Africa Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Toxin Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Toxin Revenue Market Share by Country in 2020
Figure 97. Turkey Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 98. Turkey Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 100. Saudi Arabia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Toxin Sales Growth Rate (2016-2021) (K Vial)
Figure 102. UAE Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Toxin Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
皮膚充填剤・ボツリヌス毒素の世界及び中国市場 Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromus…- 皮膚フィラー・ボツリヌス毒素の世界市場 2020年 Market Overview The global Dermal Fillers and Botulinum Toxin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermal Fil…
- アンチエイジング製品及び治療の世界市場 2020年 Market Overview The Anti-Aging Products and Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 世界のアンチエイジングボトックス市場インサイト・予測（～2027年） Anti-aging Botox treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging. …
- アンチエイジング薬の世界及び中国市場 Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging. …